HOTLINE 24/7/365 UK: +44 (0) 1483 212150

GMP Expertise

The quality of the medicines, cosmetics, vaccines, biologics and other products produced by a Company, throughout the entire process, from the post-marketing, pre-clinical and clinical phases is paramount to its success.

Regulatory Agencies have zero tolerance to product defects as a result of poor quality.  The expectation is for products to reach the highest standards of purity and conformance to specification. This requires accurate and thorough testing of all materials used to produce the final finished form of the product.

During the clinical trial phase, the final ‘post-marketing production batch size’ may not have been finalised.  The scaling up of the batch sizes can potentially result in quality issues.  The processes involved have to be considered and documented fully in terms of what was done to test the stability of the product quality during production, no matter what the batch size.

PharSafer® partners with experienced GMP and GLP Companies in this area.  They all have the key experience and audit skills for potential Regulatory Inspections, meaning that they can carry out audits of manufacturing sites to ensure they are suitable and prepared for a Regulatory Inspection.

PharSafer® Tweets

Also save on multiple bookings when attending with a colleague! - 30% off the 2nd delegate - 40% off the 3rd delega… t.co/ri9NKcJQrj

Read on Twitter...

This online course will be led by our CEO Graeme Ladds and hosted by @mfconferences ;perfect for industry professio… t.co/tZWFvbI08n

Read on Twitter...

📅 TOMORROW - 20th January There's still time to book your place on our upcoming course in producing and maintainin… t.co/GMFVI2234T

Read on Twitter...